WANG; Xiu C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for WANG; Xiu C..The latest application filed is for "2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof".

Company Profile

1.11.13

WANG; Xiu C. - Green Oaks IL
Wang; Xiu C. - Libertyville IL
Wang, Xiu C. - Gurnee IL
Wang; Xiu C. - Park City IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
2,2-difluoropropionamide Derivatives Of Bardoxolone Methyl, Polymorphic Forms And Methods Of Use Thereof App 20220073559 - SHEIKH; Ahmad Y. ; et al.	2022-03-10
2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof Grant 11,117,927 - Sheikh , et al. September 14, 2	2021-09-14
2,2-difluoropropionamide Derivatives Of Bardoxolone Methyl, Polymorphic Forms And Methods Of Use Thereof App 20200062800 - Sheikh; Ahmad Y. ; et al.	2020-02-27
2,2-difluoropropionamide Derivatives Of Bardoxolone Methyl, Polymorphic Forms And Methods Of Use Thereof App 20180094020 - Sheikh; Ahmad Y. ; et al.	2018-04-05
2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof Grant 9,856,286 - Sheikh , et al. January 2, 2	2018-01-02
2,2-difluoropropionamide Derivatives Of Bardoxolone Methyl, Polymorphic Forms And Methods Of Use Thereof App 20140323579 - Sheikh; Ahmad Y. ; et al.	2014-10-30
HIV Protease Inhibiting Compounds App 20140194349 - DeGoey; David A. ; et al.	2014-07-10
Prodrugs of HIV protease inhibitors Grant 8,426,388 - DeGoey , et al. April 23, 2	2013-04-23
HIV protease inhibiting compounds Grant 7,834,043 - DeGoey , et al. November 16, 2	2010-11-16
Prodrugs Of Hiv Protease Inhibitors App 20100286032 - DeGoey; David A. ; et al.	2010-11-11
HIV Protease Inhibiting Compounds App 20100249181 - DeGoey; David A. ; et al.	2010-09-30
Prodrugs of HIV protease inhibitors Grant 7,718,633 - DeGoey , et al. May 18, 2	2010-05-18
Prodrugs of HIV protease inhibitors App 20070270383 - DeGoey; David A. ; et al.	2007-11-22
Process for the preparation of iopamidol Grant 7,282,607 - Lorenzini , et al. October 16, 2	2007-10-16
Process for the Preparation of Iopamidol App 20070078281 - Lorenzini; Richard A. ; et al.	2007-04-05
Process for the preparation of iopamidol Grant 7,115,778 - Lorenzini , et al. October 3, 2	2006-10-03
Process for the preparation of iopamidol App 20050192465 - Lorenzini, Richard A. ; et al.	2005-09-01
HIV protease inhibiting compounds App 20050148623 - DeGoey, David A. ; et al.	2005-07-07
Process for the preparation of iopamidol Grant 6,875,887 - Lorenzini , et al. April 5, 2	2005-04-05
Process for the preparation of iopamidol App 20040236150 - Lorenzini, Richard A. ; et al.	2004-11-25
Process for the preparation of iopamidol Grant 6,803,485 - Lorenzini , et al. October 12, 2	2004-10-12
Process for producing 13-cis retinoic acid App 20010018533 - Wang, Xiu C. ; et al.	2001-08-30
Process for the preparation of fluorinated benzoic acids Grant 5,576,455 - Wang , et al. November 19, 1	1996-11-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.